サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1379012

放射性医薬品市場レポート：製品タイプ、用途、最終用途、地域別、2023-2028年

Radiopharmaceuticals Market Report by Product Type, Application, End Use, and Region 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 140 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
放射性医薬品市場レポート：製品タイプ、用途、最終用途、地域別、2023-2028年
出版日: 2023年11月02日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

世界の放射性医薬品市場規模は2022年に52億米ドルに達しました。今後、IMARC Groupは、市場は2028年までに73億米ドルに達し、2022年から2028年の間に5.8%の成長率（CAGR）を示すと予測しています。

放射性医薬品は放射性同位元素からなる独自の製剤で、臨床分野で診断や治療に使用されます。これらの医薬品は、核医学を専門とする医療専門家である放射線薬剤師によって投与されます。錠剤の形で服用されるか、患者の体の静脈や空洞に注射されます。放射性医薬品が標的とする場所に到達すると、放射性薬剤を放出して腫瘍細胞を破壊します。その結果、放射性医薬品は甲状腺がん、脳腫瘍、リンパ腫、骨に転移したその他のがんの治療に使用されています。

放射性医薬品の市場動向：

高齢化社会の到来と不健康な食事パターンによるがん性疾患の増加は、世界中で放射性医薬品の使用が増加している主な要因です。これとは別に、診断センター数の増加も市場を支えています。さらに、がん細胞の発生に関与する特定のタンパク質や遺伝子を標的とする薬剤を利用する疾患標的がん治療を提案する腫瘍専門医の数が増加していることも、全体的な売上にプラスの影響を与えています。さらに、放射線標識ペプチドやモノクローナル抗体のがん腫瘍の診断や治療への利用が、医療費の増加とともに市場の成長を強めています。市場の成長を促進すると予想されるその他の主な要因には、体全体の放射能を追跡してがん細胞の存在を判定するために腫瘍医が放射性医薬品を使用するようになっていること、陽電子放射断層撮影法（PET）および単一光子放射コンピュータ断層撮影法（SPECT）スキャンへのシフトが増加していることなどがあります。

本レポートで扱う主な質問

  • 2022年の世界の放射性医薬品市場規模は？
  • 2023年～2028年の放射性医薬品の世界市場の予想成長率は？
  • COVID-19が世界の放射性医薬品市場に与えた影響は？
  • 放射性医薬品の世界市場を牽引する主要因は？
  • 放射性医薬品の世界市場の製品タイプ別区分は？
  • 放射性医薬品の世界市場の用途別区分は？
  • 放射性医薬品の世界市場における最終用途別の内訳は？
  • 放射性医薬品の世界市場における主要地域は？
  • 放射性医薬品の世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の放射性医薬品市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品タイプ別

  • 診断用核医学
    • 市場動向
    • 市場予測
  • 治療用核医学
    • 市場動向
    • 市場予測

第7章 市場内訳：用途別

  • がん領域
    • 市場動向
    • 市場予測
  • 循環器領域
    • 市場動向
    • 市場予測
  • 神経内科
    • 市場動向
    • 市場予測
  • 内分泌学
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：最終用途別

  • 病院・クリニック
    • 市場動向
    • 市場予測
  • 調査機関
    • 市場動向
    • 市場予測
  • 診断センター
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Advanced Accelerator Applications（Novartis AG）
    • Bayer AG
    • Bracco S.p.A.
    • Cardinal Health Inc.
    • Curium Pharma
    • General Electric Company
    • IBA RadioPharma Solutions
    • Jubilant Pharma Limited
    • Lantheus Medical Imaging Inc
    • Nordion Inc.（Sotera Health）
    • NTP Radioisotopes SOC Ltd
    • PharmaLogic Holdings Corp.
    • Siemens AG
図表

List of Figures

  • Figure 1: Global: Radiopharmaceuticals Market: Major Drivers and Challenges
  • Figure 2: Global: Radiopharmaceuticals Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Radiopharmaceuticals Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Radiopharmaceuticals Market: Breakup by Product Type (in %), 2022
  • Figure 5: Global: Radiopharmaceuticals Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Radiopharmaceuticals Market: Breakup by End Use (in %), 2022
  • Figure 7: Global: Radiopharmaceuticals Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Radiopharmaceuticals (Diagnostic Nuclear Medicine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Radiopharmaceuticals (Diagnostic Nuclear Medicine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Radiopharmaceuticals (Therapeutic Nuclear Medicine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Radiopharmaceuticals (Therapeutic Nuclear Medicine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Radiopharmaceuticals (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Radiopharmaceuticals (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Radiopharmaceuticals (Cardiology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Radiopharmaceuticals (Cardiology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Radiopharmaceuticals (Neurology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Radiopharmaceuticals (Neurology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Radiopharmaceuticals (Endocrinology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Radiopharmaceuticals (Endocrinology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Radiopharmaceuticals (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Radiopharmaceuticals (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Radiopharmaceuticals (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Radiopharmaceuticals (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Radiopharmaceuticals (Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Radiopharmaceuticals (Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Radiopharmaceuticals (Diagnostic Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Radiopharmaceuticals (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: North America: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: North America: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: United States: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United States: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Canada: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Canada: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Asia-Pacific: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Asia-Pacific: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: China: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: China: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Japan: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Japan: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: India: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: India: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: South Korea: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: South Korea: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Australia: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Australia: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Indonesia: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Indonesia: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Others: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Others: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Europe: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Europe: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Germany: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Germany: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: France: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: France: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: United Kingdom: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: United Kingdom: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Italy: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Italy: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Spain: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Spain: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Russia: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Russia: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Latin America: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Latin America: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Brazil: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Brazil: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Mexico: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Mexico: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Middle East and Africa: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Middle East and Africa: Radiopharmaceuticals Market: Breakup by Country (in %), 2022
  • Figure 76: Middle East and Africa: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Global: Radiopharmaceuticals Industry: SWOT Analysis
  • Figure 78: Global: Radiopharmaceuticals Industry: Value Chain Analysis
  • Figure 79: Global: Radiopharmaceuticals Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Radiopharmaceuticals Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Radiopharmaceuticals Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Radiopharmaceuticals Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Radiopharmaceuticals Market Forecast: Breakup by End Use (in Million US$), 2023-2028
  • Table 5: Global: Radiopharmaceuticals Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Radiopharmaceuticals Market: Competitive Structure
  • Table 7: Global: Radiopharmaceuticals Market: Key Players
目次
Product Code: SR112023A3906

Abstract

The global radiopharmaceuticals market size reached US$ 5.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2022-2028.

Radiopharmaceuticals are unique formulations comprising radioisotopes that are used in clinical areas for diagnosis and therapy. These medicinal drugs are administered by a radio pharmacist, a medical professional who specializes in nuclear medicine. They are taken in the form of a pill or injected into a vein or cavity of the patient's body. Once they reach the targeted location, they release radioactive agents to destroy the tumor cells. As a result, radiopharmaceuticals are used to treat thyroid, brain, lymphoma and other types of cancer that have spread to the bones.

Radiopharmaceuticals Market Trends:

The increasing prevalence of cancerous diseases on account of the rising aging population and unhealthy dietary patterns represent the key factors contributing to the growing use of radiopharmaceuticals across the globe. Apart from this, the escalating number of diagnostic centers is also supporting the market. Moreover, the rising number of oncologists that are suggesting disease-targeted cancer therapy, which utilizes drugs to target specific proteins and genes involved in the development of cancer cells, are positively influencing the overall sales. Furthermore, the use of radiolabeled peptides and monoclonal antibodies for the diagnosis and treatment of cancerous tumors, along with rising healthcare expenditures, is strengthening the market growth. Other major factors anticipated to propel the growth of the market include the increasing use of radiopharmaceuticals by oncologists to track radioactivity throughout the body and determine the presence of cancer cells and the increasing shift towards positron emission tomography (PET) and single-photon emission computerized tomography (SPECT) scans.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global radiopharmaceuticals market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, application and end use.

Breakup by Product Type:

Diagnostic Nuclear Medicine

Therapeutic Nuclear Medicine

Breakup by Application:

Oncology

Cardiology

Neurology

Endocrinology

Others

Breakup by End Use:

Hospitals and Clinics

Research Institutes

Diagnostic Centers

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Advanced Accelerator Applications (Novartis AG), Bayer AG, Bracco S.p.A., Cardinal Health Inc., Curium Pharma, General Electric Company, IBA RadioPharma Solutions, Jubilant Pharma Limited, Lantheus Medical Imaging Inc, Nordion Inc. (Sotera Health), NTP Radioisotopes SOC Ltd, PharmaLogic Holdings Corp. and Siemens AG.

Key Questions Answered in This Report

  • 1. What was the size of the global radiopharmaceuticals market in 2022?
  • 2. What is the expected growth rate of the global radiopharmaceuticals market during 2023-2028?
  • 3. What has been the impact of COVID-19 on the global radiopharmaceuticals market?
  • 4. What are the key factors driving the global radiopharmaceuticals market?
  • 5. What is the breakup of the global radiopharmaceuticals market based on the product type?
  • 6. What is the breakup of the global radiopharmaceuticals market based on the application?
  • 7. What is the breakup of the global radiopharmaceuticals market based on the end use?
  • 8. What are the key regions in the global radiopharmaceuticals market?
  • 9. Who are the key players/companies in the global radiopharmaceuticals market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Radiopharmaceuticals Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Diagnostic Nuclear Medicine
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Therapeutic Nuclear Medicine
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Oncology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cardiology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Neurology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Endocrinology
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Diagnostic Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Advanced Accelerator Applications (Novartis AG)
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Bayer AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bracco S.p.A.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 SWOT Analysis
    • 14.3.4 Cardinal Health Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Curium Pharma
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 General Electric Company
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 IBA RadioPharma Solutions
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Jubilant Pharma Limited
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Lantheus Medical Imaging Inc
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Nordion Inc. (Sotera Health)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 SWOT Analysis
    • 14.3.11 NTP Radioisotopes SOC Ltd
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 PharmaLogic Holdings Corp.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Siemens AG
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis